Discover
NVCR
NovoCure Limited
16.69
2 x 12.13
2 x 21.37
bid
ask
-
0.03
0.18%
2 @ 04:00 PM
16.69 +0.00 (0.00%)
| Ytd | 29.08% | |
| 1y | 28.38% |
16.53
day range
16.87
9.82
52 week range
21.45
| Open | 16.70 | Prev Close | 16.72 | Low | 16.53 | High | 16.87 | Mkt Cap | 1.94B |
| Vol | 1.15M | Avg Vol | 1.50M | EPS | -1.30 | P/E | N/A | Forward P/E | -20.44 |
| Beta | 1.01 | Short Ratio | 8.44 | Inst. Own | 90.69% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-29 | 50-d Avg | 16.73 | 200-d Avg | 14.54 | 1yr Est | 27.14 |
NVCR News
marketbeat.com
NovoCure Eyes Glioblastoma Growth, Cancer Launches and EBITDA Break-Even
NovoCure NASDAQ: NVCR outlined its strategy for returning its glioblastoma franchise to growth, expa
seekingalpha.com
NovoCure Limited (NVCR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcri
NovoCure Limited (NVCR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcri